By Lisa Kerner
Charlotte, N.C., July 25 - Anulex Technologies, Inc. said it closed its third round of private equity financing, totaling approximately $20 million.
The company has raised a total of $38 million from the trio of financing rounds.
"This financing will give us the ability to build a solid infrastructure for full commercialization of our first product, the Inclose Surgical Mesh, as well as lay the foundation for future therapies to treat debilitating diseases of the spine," president and chief executive officer Michael K. McCormick said in a company news release.
New investors leading the round include MB Venture Partners and Affinity Capital with participation from existing investors Split Rock Partners, New Enterprise Associates, Delphi Ventures and SightLine Partners.
Gary D. Stevenson, managing partner of MB Venture Partners, will join Anulex's board of directors and Kristine Johnson, managing partner of Affinity Capital, will serve as a board observer.
Anulex is a privately held company based in Minneapolis developing soft tissue repair products.
| Issuer: | Anulex Technologies, Inc.
|
| Issue: | Series C financing
|
| Amount: | $20 million
|
| Investors: | MB Venture Partners (lead), Affinity Capital (lead), Split Rock Partners, New Enterprise Associates, Delphi Ventures, SightLine Partners
|
| Announcement date: | July 25
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
